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In vitro biological action of aqueous extract
from roots of Physalis angulata against
Leishmania (Leishmania) amazonensis
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Abstract
Background: Leishmaniasis is an infectious disease caused by various species of the protozoan parasites of the
Leishmania genus and transmitted by phlebotomine sandflies. The protozoa multiply in phagocytic cells, mainly
macrophages, which play an important role defending the organism from pathogens. The most effective treatment
for leishmaniasis is the chemotherapy and besides the high cost, these drugs are toxic and require a long period of
treatment. Currently, some herbal products are considered an important alternative source of a new leishmanicidal
agent, which includes the plant Physalis angulata, . We evaluated effects of an aqueous extract from roots of
Physalis angulata (AEPa) on Leishmania proliferation, morphology and also determined whether physalins were
present in the extract contributing to the knowledge of its pharmacological efficacy.
Methods: Morphological alterations were determined by light microscopy, transmission and scanning electron
microscopy. Host cell viability was evaluated by MTT, and propidium iodide. AEPa were submitted in full HRESITOF
analysis.
Results: AEPa promoted a dose-dependent reduction on promastigotes (IC50 = 39.5 μg/mL ± 5.1) and amastigotes
(IC50 = 43.4 μg/mL ± 10.1) growth. This growth inhibition was associated with several morphological alterations
observed in promastigote forms. No cytotoxic effect in mammalian cells was detected (IC50 > 4000 μg/mL).
Furthemore, the presence of physalins A, B, D, E, F, G and H were described, for the first time, in the P. angulata root.
Conclusions: Results demonstrate that AEPa effectively promotes antileishmanial activity with several important
morphological alterations and has no cytotoxic effects on host cells.
Keywords: Physalis angulata, Aqueous extract, Physalins, Leishmania amazonensis, Morphological alterations,
Macrophage viability, Antileishmanial activity
Background
American tegumentar leishmaniasis (ATL) is a parasitic
disease prevalent in many parts of the tropical and sub-
tropical world and affects 12 million people in the entire
world [1]. It is estimated that 2 million cases occur
worldwide, including more than 22.000 cases in Brazil,
with 32 % of them in the Amazon region [1, 2]. ATL is a
disease with a wide spectrum of clinical variability that
depends on both infecting species of Leishmania and the
immune response of the host [3].
Chemotherapy is the only effective treatment for this
disease. However, it is expensive and usually requires a
long-term invasive and toxic intervention. During recent
decades, studies have demonstrated that a number of
plant-derived chemical compounds may act as new
therapeutic tools against Leishmania [4–6]. One of these
agents is Physalis angulata (Solanaceae), a plant distributed
in tropical and subtropical regions of the world, including
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Amazon region that has been used traditionally as folk
medicine [7, 8]. River people from the Amazonian usually
employ the root from P. angulata for therapeutic interven-
tions for malaria, asthma, hepatitis, dermatitis, rheumatism
treatment and as anti-inflammatory agent [9–13]. The
phytochemistry of P.angulata is known to contain glu-
cocorticoids, flavonoids, withanolides and physalins [13].
Among the compounds thought to be responsible for the
leishmanicidal effects of P. angulata are the physalins,
which have been mostly isolated from the plant’s stems
and leaves [14, 15]. In addition, antiprotozoal effect of
physalins was also been reported against Plasmodium sp.
[16] and Trypanosoma cruzi [17]. Nevertheless, to isolate
enough physalins to observe the above-mentioned effects,
researchers have used large quantities of P. angulata
leaves and/or stems. As the purification process is time,
effort, and resource consuming, the trend nowadays is
to determine whether or not effective therapeutic re-
sults can be achieved from plant extracts, once extracts
and/or infusions from P. angulata are most commonly
used in popular medicine as a treatment for those in-
firmities [7, 8, 12, 13]. To date, no study has assessed
whether extracts from P. angulata’s root affect Leishmania
parasites, the main host cell (macrophage), or determined
the presence of physalins in the root extract.
Therefore, based in effective action of P. angulata against
Leishmania parasites, we reported here, for the first time,
ultrastructural alterations in promastigote forms of Leish-
mania (Leishmania) amazonensis and host cell viability
after exposure to aqueous root extract obtained from
P. angulata. In addition, we also determined the presence
of physalins in the root extract.
Methods
Plant materials
P. angulata of the family Solanaceae was collected in the
Pará state, Brazil, and identified by Dr. Ricardo Secco
(Department of Botany, Emilio Goeldi Museum) and a
voucher specimen (no. 653) was deposited in the herbar-
ium of the Emilio Goeldi Museum (Belém, Pará, Brazil).
Extraction process were carried out according to the method
described by Bastos et al. [11] and 1.0 mg/mL of aqueous ex-
tract from root of Physalis angulata (AEPa) was dissolved in
Dulbecco’s Modified Eagle’s Medium (DMEM) or RPMI and
used as the standard solution for assays.
Liquid chromatography/time-of-flight mass spectrometry
analysis
High resolution mass spectral (HRESITOF) analysis was
performed on a micrTOF II - ESI-TOF (Brucker Daltonics,
Billerica, MA, USA). The capillary voltage was monitored
at 4500 V (120 V output). A solution of NA-TFA (10 mg/
mL) was used for Internal calibration (TOF). N2 was
used at 200 °C; flow and pressure were set at 4 L/min
nebulization and 0.4 bar. Liquid chromatography was
performed with a Prominence liquid chromatography
system model LC-20A from Shimadzu Technology
(Kyoto, Japan), fitted with a diode array detector
(DAD), SPDM-20A (Shimadzu, Kyoto, Japan) working
in the range of 220–250 nm, a two pump LC-20 AD
(Shimadzu, Kyoto, Japan), and a DGU-20A-5 degasser;
a CBM-20A interface was used (Shimadzu, Kyoto, Japan).
The analysis was performed at room temperature. The op-
timal chromatographic conditions consisted of an isocratic
solvent system containing 25 % of acetronitrile in water,
delivered to the C18 Phenomenex Onyx Monolithic 3 μm
column (100 mm × 4.6 mm I.D.) at a flow rate of 0.3 mL/
min. The eluent was monitored at a 225 nm detection
wavelength.
Parasites
Leishmania (Leishmania) amazonensis (IFLA/67/BR/PH8)
promastigotes were obtained from the Evandro Chagas In-
stitute and cultured at 26 °C in NNN medium. Subse-
quently, promastigotes were cultured in RPMI medium
supplemented with 10 % fetal bovine serum (FBS), 0.2 M
glutamine, 0.125 M pyruvic acid and 5 mM penicillin/
streptomycin.
Isolation of peritoneal murine macrophages
Females BALB/c mice (6 to 8 weeks old) were euthanized
and resident macrophages were obtained by washing the
peritoneal cavities with DMEM, pH 7.2. Then, peritoneal
macrophages were allowed to adhere on round glass cov-
erslips placed 24-well culture plate in a DMEM medium
supplemented with 10 % FBS for 1 h at 37 °C in a humidi-
fied atmosphere containing 5 % CO2. After that, non-
adherent cells were washed away with phosphate buffered
saline (PBS), pH 7.2, and macrophages were incubated
overnight in DMEM medium supplemented with 10 %
FBS at 37 °C in a 5 % CO2 atmosphere. All experiments
were performed at least three times with treated and un-
treated cells. The experiments were conducted in compli-
ance with the Brazilian animal protection law (Lei Arouca
number 11.794/08) of the National Council for the
Table 1 High resolution mass spectral analysis of AEPa
compounds performed on a micrTOF II - ESI-TOF
Compound Substance Tr Theoretical m/z Experimental m/z
1 Physalin D 2.35 545.2023 545.2021
2 Physalin G 2.55 527.1917 527.1902
3 Physalin A 3.22 527.1917 527.1902
4 Physalin F 7.03 527.1917 527.1902
5 Physalin E 7.94 545.2023 545.2021
6 Physalin H 8.99 563.1684 563.1684
7 Physalin B 13.17 511.1968 511.1968
tR time retention
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Control of Animal Experimentation (CONCEA, Brazil).
The protocol was approved by the Committee on the Eth-
ics of Animal Experiments of the Federal University of
Pará (CEPAE/ICB/UFPA - grant number BIO086-12).
Antipromastigote assay
L. (L.) amazonensis promastigotes (106 parasites/mL) in
the logarithmic growth phase were inoculated in a 24-
well plate containing RPMI medium supplemented with
10 % FBS with different concentrations of AEPa, and in-
cubated at 25 °C. Every 24 h, aliquots were harvested
and promastigotes were counted in a Neubauer chamber.
Cells were counted daily up to 96 h of treatment. The
cultures were performed in triplicate. One known
antileishmanial drug (Amphotericin B) at 0.1, 0.25, 0.5
and 1 μg/mL was included as a positive control. The
inhibitory concentration (IC50) was determined using
SigmaPlot (version 12).
Antiamastigote assay
Adhered macrophages were infected with L. (L.) amazonen-
sis promastigotes (stationary growth phase) at a parasite/
macrophage ratio of 10:1 and incubated for 3 h at 37 °C
and 5 % CO2. After 1 h, free parasites were removed by
washing with PBS. Cells were treated with 20, 50 and
100 μg/mL of AEPa, respectively, for 1 h daily and in-
cubated for 3 days post infection, replacing the culture
medium. Cells were then washed with PBS, fixed with
Bouin’s fixative, stained with Giemsa and covered with
Entellan® (Merck®). The number of parasites was deter-
mined by examining three coverslips for each treatment.
At least 200 infected macrophages were counted and re-
sults were expressed as survival index when compared to
controls. The survival index was obtained by multiplying
the percentage of the infected macrophages by the mean
number of amastigotes per infected macrophage and di-
vided by the total number of macrophages. The percent-
age of inhibition was determined based in the survival
index compared with control. The inhibitory concentra-
tion (IC50) was determined using SigmaPlot (version 12).
One known antileishmanial drug Glucantime (50 μg/mL)
was included as a positive control.
Morphological Analysis of AEPA-treated L. (L.) amazonensis
promastigotes
Light microscopy (LM)
To evaluate the morphological changes induced by the
AEPa in promastigote forms of L. (L.) amazonensis, the
parasites were treated with 50 and 100 μg/mL of AEPa
for 72 h. Parasite suspension aliquots were fixed with 4 %
paraformaldehyde in 0.1 M PHEM buffer (5 mM magne-
sium chloride, 70 mM potassium chloride, 10 mM EGTA,
20 mM HEPES, 60 mM PIPES), pH 7.2, and stained with
Panotic stain Kit (Laborclin). Cells were examined using
Fig. 1 AEPa action against L. (L.) amazonenis in vitro. Growth curve of
L. (L.) amazonensis promastigotes treated with different concentrations
of Amphotericin B (AMPB) (a) and AEPa. b Growth was followed up to
96 h. c Effect of AEPa on intracellular amastigote survival of L. (L.)
amazonensis. Infected mouse peritoneal macrophages were treated
with different concentrations of the extract, for1h/day during 3 days
and with glucantime ® (GLU). Results are from experiments performed
in triplicate. *p < 0.001, *p < 0.05, ***p < 0.001 compared with control
(untreated). CTL: control
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an optical microscope Axioplan (Zeiss) and images were
obtained using a digital camera model XC 30.
Transmission Electron Microscopy (TEM)
L. (L.) amazonensis promastigotes (106) in the logarith-
mic growth phase (4 days) were treated with 50 and
100 μg/mL AEPa for 3 days. The samples were proc-
essed for conventional TEM, as described by Guimarães
et al. [18].
Scanning Electron Microscopy (SEM)
Control and treated promastigotes (50 and 100 μg/mL
AEPa) were fixed with 4 % formaldehyde and 2.5 % glu-
taraldehyde in 0.1 M cacodylate buffer, pH 7.2, for 1 h.
After fixation, the cells were placed on glass slides with
0.1 % poly-L-lysine. The cells were washed and post-fixed
in 1 % osmium tetroxide, dehydrated in graded ethanol,
critical point dried (CO2), coated with platinum and ex-
amined with a LEO 1450VP SEM.
Murine macrophage viability assays
MTT assay
The MTT assay is based on the mitochondrial-dependent
reduction of MTT 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl
tetrazolium bromide] to formazan, and this assay was
conducted following the procedure described by Rodrigues
et al. [19]. Macrophages were treated with AEPa (10–
400 μg/mL) for one hour and cultured at 37 °C, 5 % CO2
for 24 h. After treatment, cells were incubated with
0.5 mg/mL MTT for 3 h. Subsequently resulting solu-
tion was read in a microplate reader (BIO-RAD Model
450 Microplate Reader) and absorbance was recorded
at 570 nm.
Propidium iodide dye exclusion test
Control and treated macrophages (50 and 100 μg/mL
AEPa) were incubated for 30 min with 10 μg/mL of pro-
pidium iodide (PI). A total of 10.000 events were ac-
quired for each sample in the region that corresponded
to the parasites by flow cytometer BD FACSCantoII and
analyzed with BD FACS Diva software. Cells labeled with
the PI were considered dead.
Statistical analysis
The differences between mean values in the experimen-
tal groups were performed using ANOVA followed
Tukey’s post test. All P-values < 0.05 were considered
statistically significant. The means and SD of at least
three experiments were determined.
Results
Identification of AEPa components by mass spectrometry
analysis
To identify the possible active principle(s) responsible
for the biological and morphological effects described
above, we submitted AEPa to HRESITOF analysis. Sev-
eral peaks were observed in the eluent from the liquid
chromatography column. Among them, we identified
the physalins A, B, D, E, F, G and H (Table 1).
Antileishmanial activity of AEPa
The effect of AEPa on L. (L.) amazonensis promastigotes
was monitored for 4 days. Reductions of 100 % were ob-
served in the number of viable parasites at 0.5 and 1 μg/
mL Amphotericin B, respectively, after 96 h of incuba-
tion, representing an IC50 of 0.02 μg/mL ± 0.021 (Fig. 1a).
In contrast, the AEPa induced dose-dependent reduc-
tions in parasite proliferation of 74.1 % and 99.8 % after
96 h of treatment with 50 μg/mL and 100 μg/mL AEPa,
respectively, representing an IC50 of 39.5 μg/mL ±
5.1 μg/mL (Fig. 1b).
Effect of AEPa on L. (L.) amazonensis intracellular
amastigotes
The leishmanicidal activity of AEPa was also evaluated
in L. (L.) amazonensis-infected macrophage cultures. A
reduction in parasite survival was observed for all AEPa
concentrations tested. However, more significant results
were found at 50 μg/mL and 100 μg/mL of AEPa,
achieving reductions of 70.6 % and 70.9 %, respectively
(IC50 43.3 μg/mL ± 10.1; Fig. 1c). Glucantime (GLU -
Figure 1c) and amphotericin B (AMPB - Additional file
1) were added as reference drugs.
LM analysis of AEPa-treated L. (L.) amazonensis
promastigotes
L. (L.) amazonensis promastigotes were analyzed by LM
to detect morphological alterations. Untreated parasites
showed a typical morphology with an elongated body
and a single flagellum (Fig. 2a). After 72 h of treatment
with 50 μg/mL and 100 μg/mL of AEPa, promastigotes
presented a rounded shape, two flagella and a reduction
in cell body (Fig. 2b and c). In addition, treated cultures
presented debris suggestive of cellular fragments.
SEM analysis of AEPa-treated L. (L.) amazonensis
promastigotes
SEM was used to further investigate the morphological al-
terations observed by light microscopy. Promastigotes
treated with 50 μg/mL AEPa presented flagellum duplica-
tion and atypical cell division (Fig. 3b). When promasti-
gotes were treated with 100 μg/mL AEPa, their rounded
appearance became more evident, the body was frequently
multi-septated, and the flagellum shortened (Fig. 3c and
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Fig. 2 Light microscopy of promastigote forms of L. amazonensis treated with AEPa for 3 days. a Control parasite; b Promastigotes treated with
50 μg/mL of AEPa. Arrow indicates parasites with two flagella. c Promastigotes treated with 100 μg/mL AEPa. Note reduction in the cell size and
rounded cell body (arrow). Bars: 20 μm
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c). Moreover, SEM analysis suggest that the debris ob-
served by LM is likely to be cellular fragments around the
parasites (Fig. 3d).
TEM analysis of AEPa-treated L. (L.) amazonensis
promastigotes
TEM was used to analyze alterations in the parasite or-
ganelles. Promastigotes treated with 50 μg/mL AEPa
showed changes in the flagellar membrane that presents
some vacuoles near the flagellar pocket membrane
(Fig. 4b). When 100 μg/mL AEPa was used, we observed
alterations in the kinetoplast’s shape with swelling and
duplication of its DNA. Alterations were also observed
in the flagellar pocket, where myelin-like structures and
the presence of vesicles were seen (Fig. 4c and d). Fur-
thermore, atypical cell division was observed (Fig. 4b), as
shown by SEM.
Effects of AEPa on macrophage viability
To test the selectivity of AEPa for the L. (L.) amazonen-
sis parasite, murine macrophages were treated with the
extract and the viability of these cells was assessed by
the MTT reduction and PI. No cytotoxic effect of 10–
400 μg/mL of AEPa treatment on macrophages was ob-
served with the MTT assay (Fig. 5a). No differences were
detected in the intensity of the red fluorescence in mac-
rophages stained with PI dye (Fig. 5b) when compared
treated and untreated macrophages.
Discussion and conclusions
Bioproducts obtained from plants offer perspectives for the
discovery of new active and promising compounds with
antileishmanial activity. Extracts and physalins obtained
from P. angulata have shown a vast range of biological
properties [10, 11, 14–16, 20, 21]. However, to date, no re-
ports have described the morphological alterations in para-
sites of Leishmania genus in response to AEPa treatment.
Results showed that 100 μg/mL AEPa induce 99.8 %
antileishmanial activity against L. amazonensis promasti-
gotes (IC50 of 39.5 μg/mL ± 5.1). A similar concentration
of flower and leaf extracts from Cymbopogon citratus,
Matricaria chamomilla and Piper regnellii Miq. [5]
achieved around 98 % antileishmanial activity against L.
amazonensis promastigotes. As such, AEPa seems to
have a comparable growth inhibitory effect on promasti-
gotes to these other plant extracts. However, they are
Fig. 3 Scanning electron microscopy of promastigotes of L. amazonensis treated with AEPa from Physalis angulata after incubation for 3 days. a
Control. b Parasites after treatment with 50 μg/mL AEPa. Observe the flagellum and cell doubling in apparent atypical cell division, and multi-septation
of the cell body (arrows). c and d Parasites after treatment with 100 μg/mL AEPa. Observe reduction in the parasite body, multi-septation of the cell
body (white arrows) and of the flagellum. Note the presence of cellular debris around parasite (arrows). Bars: (a) 3 μm (b-d) 1.5 μm
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clearly more potent than some plant extracts that have
reported a maximum of 90–96 % of antileishmanial ac-
tivity against L. amazonensis promastigotes [5, 22].
One of the novel findings of the present study is the de-
scription of morphological alterations caused in promasti-
gotes forms following incubation with AEPa. Electron
microscopy techniques can be a useful tool in drug studies
for the identification of cell surfaces and ultrastructural al-
terations, as well as specific organelle targets in the para-
sites. Indeed, identification of morphological changes can
help elucidate the mechanisms of drug action [23, 24].
Treatment of promastigotes with 50 or 100 μg/mL AEPa
caused a reduction and rounding of the body cellular vol-
ume, as well as flagellum duplication, as shown by LM
and SEM. Duran et al. [25] observed similar changes in
the body shape and flagellum of promastigotes treated
with an ethanolic extract of Adana propolis. However,
these authors used concentrations of 250 and 500 μg/mL
against L. tropica. Santin et al. [26] showed atypical flagella
duplication in L. amazonensis promastigotes treated with
oil from Cymbopogon citratus. In a review published by
Adade and Souto-Padrón. [24], the authors suggested that
these alterations may be caused by the interference of drugs
and plant extracts in the process of cell division. Since the
division process of L. amazonensis promastigotes treated
with AEPa initiated at the posterior instead of the normal
anterior position [27, 28], it is possible that the extract inter-
fered with the division process of these cells.
SEM analysis revealed cellular debris and body multi-
septation in promastigotes treated with AEPa. Studies
with Cymbopogon citratus oil against promastigotes of L.
chagasi showed multi-septation, and shortening of the cell
body and flagellum [29]. This alteration could be caused
by cytoskeleton disassembly [24]. In addition, TEM ana-
lysis showed the presence of multiple vesicles within the
flagellar pocket of AEPa treated-promastigotes. The
Fig. 4 Ultrastructural effects of AEPa on promastigotes of Leishmania (L.) amazonensis. a General view of untreated parasite showing the
characteristic structure of kinetoplastids. b Promastigotes treated with 50 μg/mL AEPa for 3 days. Note some vacuoles in the membrane of
flagellar pocket (*) and alterations in flagellar membrane (arrow). c and d General view of promastigotes treated with 100 μg/ml AEPa for 3 days.
c Observe the presence of myelin-like structures in the flagellar pocket (arrows) and duplication of kinetoplast DNA (arrowhead). (d) Note the
presence of a large number of vesicles inside the flagellar pocket (*) and alterations in shape and swelling of kinetoplast (arrowheads). N, nucleus;
FP, flagellar pocket; K, kinetoplast; F, flagellum; M, mitochondria. Bars represent A 5 μm; B 2 μm; C 5 μm; C inset 2 μm; D 2 μm
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uptake of macromolecules by promastigotes occurs
through the flagellar pocket, which is an invagination of
the plasma membrane, devoid of microtubules. This re-
gion is the only place where exocytic and endocytic activ-
ity occurs [30]. In promastigotes submitted to drug and/or
plant extracts treatments, this increased exocytic activity
probably occurs to expel the toxic compound [18, 31]. It
is likely that the multiple vesicles observed may be
employed by L. amazonensis promastigotes for the re-
moval of the toxic compounds present in the AEPa.
Myelin-like figures were also observed in the promasti-
gotes treated with AEPa. These structures are a result of
the merging of internal membranes to form concentric
structures, which may be indicative of an autophagic
process [18, 32, 33] as observed by Meira et al. [17] in Try-
panosoma cruzi. Another characteristic feature seen in
AEPa-treated promastigotes was the structural modifica-
tions of the kinetoplast, such as duplication, and shape
and size alterations. Several authors, using plant products,
demonstrated similar kinetoplast alterations [18, 34]. The
kinetoplast is a unique organelle present only in trypano-
somatid protozoa and is, thus, a potential drug target due
to its unique structure and function, which is matched in
its mammalian host [24, 30, 35].
Additionally, treatment of intracellular amastigotes of
Leishmania (L.) amazonensis with 100 μg/mL AEPa led
to a growth inhibitory effect of 70.9 % (IC50 43.3 μg/mL
± 10.1). Luize et al. [5] also showed an inhibitory effect
of 92–96 % with Cymbopogon citratus, Matricaria cha-
momilla and Piper regnellii Miq. extracts when tested
against amastigotes. However, it is not possible to dir-
ectly compare the inhibitory effects of this study with
our results, since authors used axenic amastigote cul-
tures instead of amastigotes inside host cells. In previous
reports, Guimarães et al. [14, 15] showed that physalins
B, F and G, purified from stems of P. angulata, were able
to reduce promastigote (IC50 = 6.8, 1.4, and 9.2 μM, re-
spectively) and axenic amastigotes number (IC50 = 0.21
and 0.18 μM for Physalin B and F, respectively) and per-
centage of Leishmania-infected macrophages at concen-
trations non-cytotoxic to macrophages. However, no
reports have described morphological alterations in par-
asites. Our study evaluated the antileishmanial effect of
AEPa and also morphological alterations indicative of
abnormalities in the cell division process. We detected,
for the first time, the presence of physalins A, B, D, E, F,
G and H in the AEPa, isolated from roots, and believes
that these morphological and physiological changes
Fig. 5 Host cell viability assays. a MTT assay. The viability of the untreated control was taken as 100 %. The viability percentage was calculated for different
concentrations of AEPa. No significant differences were found at 10–400 μg/ml of AEPa when compared with the control. b Propidium iodide (PI) exclusion
test at 50 and 100 ug/mL in comparison to the control (CTL). No significant differences were observed in macrophages stained with PI dye
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could be related to the presence of these physalins in the
AEPa. Furthermore, cytotoxicity tests were employed to
verify whether AEPa was selectively toxic against the
parasite, therefore sparing the host cell. The assays used
did not detect significant changes in host cell viability,
suggesting AEPa was specific for the protozoa.
Taken together, our results indicate that the AEPa pro-
motes morphological alteration in promastigotes, a dose-
dependent reduction of promastigotes and amastigotes of
Leishmania, and have no cytotoxic effects on the host cell.
To our knowledge this report is the first ultrastructural ana-
lysis of the actions of the aqueous extract from P. angulata
on Leishmania and could be helpful for understanding pos-
sible mechanisms of action of this agent on parasites and
host cells. Therefore, this study is part of a continual search
for new drugs, obtained from medicinal plants widely used
in Amazon region that can act effectively against neglected
diseases such as leishmaniasis.
Additional file
Additional file 1 Effect of AMPB on L. (L.) amazonensis intracellular
amastigotes. Infected mouse peritoneal macrophages were treated with
different concentrations AMPB for 24h. ***p < 0.001 compared with
control (CTL).
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